A number of studies proposed that HE4 has a higher sensitivity compared to CA125 in early detection of endometrial cancer and ovarian cancer in early stages, which indicates the potential of HE4 to predict the recurrence of cancer (37). The gene discussed is WFDC2; the disease is cancer.